Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Management of Cerebral Venous Thrombosis (CVT)

Diagnostic Confirmation

  • MRI with T2*-weighted imaging plus MR venography is the preferred diagnostic method for confirming CVT in patients with suspected cerebral venous thrombosis, according to the American Heart Association 2
  • CT venography can be used if MRI is not readily available for patients with suspected CVT, as recommended by the American Heart Association 2
  • Catheter angiography may be needed in select cases with high clinical suspicion but negative initial imaging for CVT diagnosis, as suggested by the American Association of Neurological Surgeons 1

Initial Management Algorithm

  • Immediate anticoagulation with either intravenous unfractionated heparin or subcutaneous low-molecular-weight heparin is the first-line treatment for cerebral venous thrombosis, even in the presence of hemorrhagic lesions, as recommended by the American Heart Association 1, 2
  • The presence of intracranial hemorrhage related to CVT is NOT a contraindication to anticoagulation, according to the American Heart Association 2
  • Monitor patients closely in a stroke unit or neurocritical care setting for CVT management, as suggested by the American Association of Neurological Surgeons 5

Supportive Care

  • Provide symptomatic therapy for seizures and increased intracranial pressure in patients with CVT, as recommended by the American Association of Neurological Surgeons 1

Long-term Management

  • After initial heparin therapy, transition to oral anticoagulation for long-term CVT management, as recommended by the American College of Chest Physicians 3, 4
  • Duration of anticoagulation depends on underlying etiology, with 3-6 months for transient risk factors, 6-12 months for unprovoked CVT or low-risk thrombophilia, and indefinite anticoagulation for severe thrombophilia or recurrent thrombosis, as suggested by the American College of Chest Physicians 1, 3, 4

Prognostic Factors and Pitfalls

  • Underlying prothrombotic conditions should be investigated as this affects treatment duration in patients with CVT, as recommended by the American Heart Association 5
  • Failure to recognize neurological deterioration can occur in some patients with CVT, highlighting the need for close monitoring, as suggested by the American Association of Neurological Surgeons 5

Follow-up

  • Follow-up imaging at 3-6 months after diagnosis is reasonable to assess for recanalization in patients with CVT, as recommended by the American College of Radiology 3